McGill Case 87: Difference between revisions

Jump to navigation Jump to search

McGill Case 87 (view source)

Revision as of 03:05, 15 February 2012

1,078 bytes added ,  15 February 2012
no edit summary
(Created page with "{{McGillcase| |previouspage= McGill Case 86 |previousname= McGill Case 86 |nextpage= McGill Case 88 |nextname= McGill Case 88 }} [[File:E0007871.jpg|thumb|600px|left|These ar...")
 
No edit summary
Line 6: Line 6:
}}
}}


[[File:E0007871.jpg|thumb|600px|left|These are two strips from a 90 year old patient with a pacemaker.
[[File:E000788.jpg|thumb|600px|left|Comment
The pacemaker was past end of life and one paced beat can be seen in the top strip. Note the pacemaker was not sensing at this time. The patient's rhythm is complete heart block (note the slight variation in the pr interval which supports this interpretation)


The Second strip shows Torsade de Pointe ventricular tachycardia, note the long QT interval >600ms., the polymorphic morphology and the late coupled PVC the induces the run.  
This is a classic 12 lead EKG of a patient with Torsade de Pointes.


Replacement of the pacemaker terminated the arrhythmia.]]
It shows


[[File:E0007872.jpg|thumb|600px|left|]]
the polymorphic nature of the tachycardia,
the long QT interval and
the initiation of the tachycardia with a late coupled P.V.C.
Torsade is a polymorphic tachycaridia that is associated with prolongation of the QT interval (usually greater than 600 ms) and can be acquired or congenital. This arrhythmia was responsible for Quinidine syncope and is an important cause of sudden death in patients treated with type I and type III antiarrhythmic medications. The electrical mechanism may be related to dispersion of repolarization or to triggered activity associated with after depolarizations.
 
Besides medications, acquired Torsade can be associated with hypokalemia, and a slow heart rate (complete heart block). This patient was a renal patient on dialysis who was admitted to hospital for an E.N.T. operation on one of her sinuses. The arrhythmia was noted during the operation. At the time of the procedure she was taking sotalol and this combined with her renal failure was the presumed cause of the arrhythmia.
 
Sotalol has both class II (beta-blocking) and class III (prolonging of action potential) effects. Sotalol is excreted mainly by the kidneys and the dosing intervals should be lengthened when the creatinine clearance is less than 60 ml/min. As with the anti-arrhythmic effect of sotalol, Torsade de pointes is dose dependent and occurs in 0.5 percent of patients who taking 160 mg/day, 1.6 % taking 320 mg/day, and up to 5.8% taking more than 320 mg/day.
 
The arrhythmia in this patient did not recurred post-operatively with the sotalol removed from her medications.]]
Retrieved from "https://en.ecgpedia.org/index.php?title=Special:MobileDiff/14756"

Navigation menu